MindWalk Holdings Corp. Logo

MindWalk Holdings Corp.

A Bio-Native AI company that integrates AI and lab research for drug discovery.

HYFT | US

Overview

Corporate Details

ISIN(s):
CA45257F2008
LEI:
Country:
United States of America
Address:
INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300, 78701 AUSTIN

Description

MindWalk Holdings Corp. is a Bio-Native AI company that focuses on transforming drug discovery and development. The company operates a biointelligence ecosystem that integrates artificial intelligence, multi-omics data, and advanced laboratory research to make complex biology computable and actionable. This unified platform is designed to accelerate the discovery and development of biologics, including therapeutic antibodies, diagnostics, vaccines, and peptide therapeutics, from target identification through to the clinical stage. Its capabilities are powered by proprietary technologies such as the patented HYFT® technology and the LensAI™ platform, which are adaptable to specific targets, modalities, and program priorities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all MindWalk Holdings Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MindWalk Holdings Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MindWalk Holdings Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nicox S.A. Logo
Ophthalmology company developing therapies based on a nitric oxide-donating platform.
France
COX
NLS Pharmaceutics Ltd. Logo
Clinical-stage biopharma firm developing therapies for rare and complex CNS disorders.
United States of America
NLSP
NovoCure Ltd Logo
Develops a non-invasive cancer therapy using electric fields to disrupt solid tumors.
United States of America
NVCR
NUFORMIX PLC Logo
Pharmaceutical developer using cocrystal technology to repurpose drugs for fibrosis.
United Kingdom
NFX
Nurix Therapeutics, Inc. Logo
Clinical-stage biopharma developing protein degradation therapies for various diseases.
United States of America
NRIX
OLIPASS CORPORATION Logo
An R&D company developing RNA therapeutics using its proprietary OPNA platform.
South Korea
244460
A technology platform for therapeutic antibody discovery using transgenic animals.
United States of America
OABIW
ONCIMMUNE HOLDINGS PLC Logo
Immunodiagnostics company specializing in antibody and autoantibody biomarker signatures.
United Kingdom
ONC
Oncocross Co.,Ltd. Logo
An AI biotechnology firm that develops drugs by predicting drug-disease interactions.
South Korea
382150
ONCODESIGN Logo
Develops therapeutic and diagnostic solutions for resistant and metastatic cancers.
France
ALONC

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.